SMi Reports: Two exclusive interviews with Lacey Batts at Novo Nordisk and Joanny Salvas at Pfizer, speaking at the 4th Annual Pharma Microbiology East Coast
Online PR News – 11-February-2021 – Boston, MA – The Pharmaceutical Microbiology Conference East Coast Virtual Conference will be commencing on 28th and 29th April 2021 and will focus on implementing robust sterility assurance strategies for effective contamination control.
SMi Group caught up with Lacey Batts, QC Biochemist II, QC Microbiology & Biochemistry T Novo Nordisk and Joanny Salvas, Manager, PAT Projects at Pfizer.
Lacey Batts as a Biochemist II (Microbiologist II) in QC at Novo Nordisk Pharmaceutical-Site Clayton, works with the Cleaning Validation team (as well the Clean Utilities team) as the direct representative for all water testing. Lacey aids in planning and preparation for all current and future cleaning validation activities and is currently involved in several method transfers/validations along with routine testing within the department.
Joanny Salvas has a bachelor’s degree in biotechnological engineering and a master’s in applied sciences (Chemical engineering). She has been developing and implementing Process Analytical Technologies for more than 10 years at Pfizer, both in Solids and Sterile Injectable processes.
Here is a snapshot of what was discussed:
What is the greatest challenge for you to personally overcome within the pharmaceutical microbiology field currently?
Lacey's Answer:' Currently I am working in a finished product facility and the project lead for Microbiology in our sister oral product facility. It has definitely been a challenge to facilitate between the 2 facilities in regard to communication, testing procedures/specifications and managing and coordinating all the different activities between all the different departments at the 2 facilities.’
The pharmaceutical microbiology industry has matured significantly in previous years, what key developments have you witnessed in the last year within the field?
Joanny's Answer: "The adoption of alternative and rapid microbiological method has increased significantly recently. We see interest and support from the different Boards of Health and auditors for the adoption of these methods (when properly developed and validated, of course!) and this is greatly encouraging!"
The full interviews can be downloaded at: http://www.microbiologyeastcoast.com/PR3
Interested in joining the conference and workshop you can register your place at http://www.microbiologyeastcoast.com/PR3
Proudly Sponsored by: bioMérieux and Microcoat
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or firstname.lastname@example.org
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or email@example.com
SMi’s 4th Annual Pharmaceutical Microbiology East Coast
Virtual Conference: Online Access Only
Conference: April 28 – 29, 2021
Workshops: April 27, 2021
--- ENDS –
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk